Anthony T. Dren

923 total citations
25 papers, 719 citations indexed

About

Anthony T. Dren is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anthony T. Dren has authored 25 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anthony T. Dren's work include Neuroscience and Neuropharmacology Research (6 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Anthony T. Dren is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Anthony T. Dren collaborates with scholars based in United States and United Kingdom. Anthony T. Dren's co-authors include Edward F. Domino, Donna Bergen, Edward Faught, Fumisuke Matsuo, G. David Rudd, Charles G. Lineberry, John A. Messenheimer, Ken Yamamoto, Takayuki Okabe and Thomas Novinson and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anthony T. Dren

25 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony T. Dren United States 13 327 296 196 145 124 25 719
Mariusz Świąder Poland 14 492 1.5× 275 0.9× 470 2.4× 35 0.2× 266 2.1× 47 732
R.A. O'Brien United States 15 142 0.4× 42 0.1× 289 1.5× 50 0.3× 246 2.0× 29 701
Wayne D. Yonekawa United States 14 212 0.6× 128 0.4× 346 1.8× 32 0.2× 217 1.8× 29 574
Hans‐Hasso Frey Germany 13 232 0.7× 142 0.5× 354 1.8× 25 0.2× 148 1.2× 24 519
Cameron S. Metcalf United States 19 364 1.1× 149 0.5× 501 2.6× 27 0.2× 242 2.0× 50 852
Jens Aas Jansen Denmark 11 214 0.7× 100 0.3× 690 3.5× 42 0.3× 469 3.8× 18 972
Piotr Czapiński Poland 5 183 0.6× 117 0.4× 143 0.7× 29 0.2× 90 0.7× 9 354
Rolf Axelsson Sweden 14 281 0.9× 45 0.2× 233 1.2× 23 0.2× 237 1.9× 31 780
Petr Mareš Czechia 15 307 0.9× 139 0.5× 521 2.7× 26 0.2× 252 2.0× 106 883
Martin J. Brodie United Kingdom 12 730 2.2× 593 2.0× 421 2.1× 19 0.1× 141 1.1× 12 924

Countries citing papers authored by Anthony T. Dren

Since Specialization
Citations

This map shows the geographic impact of Anthony T. Dren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony T. Dren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony T. Dren more than expected).

Fields of papers citing papers by Anthony T. Dren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony T. Dren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony T. Dren. The network helps show where Anthony T. Dren may publish in the future.

Co-authorship network of co-authors of Anthony T. Dren

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony T. Dren. A scholar is included among the top collaborators of Anthony T. Dren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony T. Dren. Anthony T. Dren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Gail D., Barry E. Gidal, René H. Levy, et al.. (1996). Bidirectional interaction of valproate and lamotrigine in healthy subjects*. Clinical Pharmacology & Therapeutics. 60(2). 145–156. 92 indexed citations
2.
Borison, Richard L., B.I. Diamond, & Anthony T. Dren. (1991). Does sigma receptor antagonism predict clinical antipsychotic efficacy?. PubMed. 27(2). 103–6. 20 indexed citations
3.
Borison, Richard L., Anthony T. Dren, & B.I. Diamond. (1990). Sigma receptor antagonism and antipsychotic actions in schizophrenic patients. European Journal of Pharmacology. 183(6). 2323–2323. 3 indexed citations
4.
Davidson, Jonathan, et al.. (1985). BW234: A nondopamine receptor‐blocking antipsychotic drug without extrapyramidal side effects?. Drug Development Research. 6(1). 13–17. 13 indexed citations
5.
Halaris, Angelos, et al.. (1985). Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenics. Drug Development Research. 5(4). 387–393. 17 indexed citations
6.
Zaugg, Harold E., et al.. (1983). New azacannabinoids highly active in the central nervous system. Journal of Medicinal Chemistry. 26(2). 278–280. 4 indexed citations
7.
Guy, William, et al.. (1983). Psychotropic actions of BW 234U in the treatment of inpatient schizophrenics: A dose‐range study. Drug Development Research. 3(3). 245–252. 15 indexed citations
8.
Minard, Frederick N., et al.. (1979). N-o-Methoxyphenylpiperazine: a simple blocker of dopaminergic receptors in the brain. Journal of Pharmacy and Pharmacology. 31(1). 91–93. 6 indexed citations
9.
Dren, Anthony T., et al.. (1978). Local Anesthetic Activity and Acute Toxicity of N-Substituted 1,2,3,4-Tetrahydro-1- and 2-naphthylamines. Journal of Pharmaceutical Sciences. 67(6). 880–882. 3 indexed citations
10.
Bopp, Barbara A., et al.. (1978). Local Anesthetic Activity and Acute Toxicity of N-Heptyl-1,2,3,4-tetrahydro-6-rnethoxy-1-naphthylamine Methanesulfonate. Journal of Pharmaceutical Sciences. 67(6). 882–884. 2 indexed citations
11.
Zaugg, Harold E., et al.. (1977). Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives. Journal of Medicinal Chemistry. 20(11). 1508–1511. 8 indexed citations
12.
13.
Razdan, Raj K., G. R. HANDRICK, H. C. DALZELL, et al.. (1976). Drugs derived from cannabinoids. 3. Sulfur analogs, thiopyranobenzopyrans and thienobenzopyrans. Journal of Medicinal Chemistry. 19(4). 549–551. 12 indexed citations
14.
Winn, Martin, et al.. (1976). Drugs derived from cannabinoids. 5. .DELTA.6a,10a,-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. Journal of Medicinal Chemistry. 19(4). 461–471. 19 indexed citations
15.
Razdan, Raj K., G. R. HANDRICK, H. C. DALZELL, et al.. (1976). Drugs derived from cannabinoids. 4. Effect of alkyl substitution in sulfur and carbocyclic analogs. Journal of Medicinal Chemistry. 19(4). 552–554. 6 indexed citations
16.
Razdan, Raj K., et al.. (1976). Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs. Journal of Medicinal Chemistry. 19(4). 454–461. 22 indexed citations
17.
Razdan, Raj K., Benoı̂t Terris, G. R. HANDRICK, et al.. (1976). ChemInform Abstract: DRUGS DERIVED FROM CANNABINOIDS. 3. SULFUR ANALOGS, THIOPYRANOBENZOPYRANS AND D THIENOBENZOPYRANS. Chemischer Informationsdienst. 7(31). 2 indexed citations
18.
Rosecrans, John A., Anthony T. Dren, & Edward F. Domino. (1968). Effects of physostigmine on rat brain acetylcholine, acetylcholinesterase and conditioned pole jumping. International Journal of Neuropharmacology. 7(2). 127–134. 36 indexed citations
19.
Dren, Anthony T. & Edward F. Domino. (1968). EFFECTS OF HEMICHOLINITJM (HC-3) ON EEG ACTIVATION AND BRAIN ACETYLCHOLINE IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 161(1). 141–154. 3 indexed citations
20.
Domino, Edward F., Anthony T. Dren, & Ken-ichi Yamamoto. (1967). Pharmacologic Evidence for Cholinergic Mechanisms in Neocortical and Limbic Activating Systems. Progress in brain research. 27. 337–364. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariusz Świąder Breakdown of academic impact, for papers by R.A. O'Brien Breakdown of academic impact, for papers by Wayne D. Yonekawa Breakdown of academic impact, for papers by Hans‐Hasso Frey Breakdown of academic impact, for papers by Cameron S. Metcalf Breakdown of academic impact, for papers by Jens Aas Jansen Breakdown of academic impact, for papers by Piotr Czapiński Breakdown of academic impact, for papers by Rolf Axelsson Breakdown of academic impact, for papers by Petr Mareš Breakdown of academic impact, for papers by Martin J. Brodie
Rankless by CCL
2026